Skip to content

CLEARaudit

← All CLEAR tools
AI ASSURANCE

CLEARaudit

Transforming radiology audit with AI

Intelligent audit and service insight for modern imaging systems. A scalable, clinically validated approach that interrogates entire imaging datasets within a defined clinical pathway and produces actionable insight for service improvement.

Clinician at a diagnostic reporting workstation
Whole
dataset analysis — no reliance on small manual samples
2–3 wks
typical analysis and reporting turnaround once IG is complete
7
imaging pathways available, priced per pathway
£22.5k
indicative cost for a full single-pathway audit (ex-VAT)
Executive summary

Audit on steroids — for imaging services under sustained pressure

Radiology services are under sustained pressure from rising demand, workforce constraints, and increasing expectations around governance, productivity and sustainability. Traditional audit approaches often struggle to keep pace, relying on manual sampling, limited scope and long turnaround times.

CLEARaudit combines AI-enabled interrogation of free-text radiology reports with structured data — and, where relevant, linked contextual data such as laboratory results — alongside a senior clinical validation step. It is delivered per pathway, and the commercial model is transparent and scalable.

In practice, organisations use the audit to:

Understand demand and variation within a pathway (e.g. referral sources, day vs night scanning).
Assess diagnostic yield and positivity, and how it changes over time or between subgroups.
Identify opportunities to improve vetting, pathway compliance and resource allocation.
Generate evidence to support internal change management and governance requirements.
Enable closed-loop re-audit following an intervention to demonstrate measurable impact.
Why it matters now

Four pressures making large-scale audit essential

Workforce and capacity

Imaging demand is increasing while workforce capacity and scanner availability remain constrained. Without better insight into where imaging adds value, services risk escalating backlogs and clinician workload.

Variation and unwarranted demand

Variation in referral behaviour, vetting processes and pathway enforcement can generate unwarranted demand. Understanding variation at scale is a prerequisite for targeted improvement.

Governance and assurance

Clinical services increasingly require audit and evaluation to demonstrate appropriate use of imaging, guideline adherence and continuous improvement. Large-scale dataset interrogation provides stronger evidence than small samples.

Productivity and sustainability

CT and MRI are among the most resource-intensive activities in hospitals, with significant operational costs and carbon footprint. Reducing low-value imaging supports both financial and sustainability goals.

What makes it different

Beyond traditional audit

Importantly, the AI is not positioned as a black box. Outputs are clinically reviewed and validated, and your organisation retains ownership of decisions and change management.

Traditional audit
Manual sampling with limited cohort sizes
Labour-intensive clinician time for extraction
Long turnaround; hard to repeat
Often descriptive — what happened
Limited segmentation and comparison
CLEARaudit
Whole-dataset analysis where available
AI extracts insights from free text at scale
Repeatable runs enable closed-loop audit
Action-oriented — why variation exists and where to intervene
Flexible segmentation by time, referrer and cohort

Pathway-led

Each investigation is treated as a separate audit unit and can be priced separately.

Whole-dataset capable

We can analyse all records provided for the pathway, not small samples.

Clinically assured

AI outputs and any recommendations are subject to clinical validation.

Operationally useful

Outputs inform service transformation, not just reporting compliance.

Repeatable

Once set up, the same pathway can be re-run to support closed-loop audit.

Clinical pathways in scope

Delivered per pathway, per dataset

The examples below illustrate typical pathway questions; specific questions are agreed during scoping.

CT Pulmonary Angiography (CTPA)

Demand vs positivity: is rising demand associated with rising PE detection?
D-dimer utilisation, where linked: how does positivity vary by threshold bands?
Day vs night scanning: is out-of-hours scanning associated with different yield?
Referral source variation and improvement levers for vetting and decision support.

CT Abdomen & Pelvis (acute)

Demand vs positivity: does increased scanning correspond to more pathology?
Cohort segmentation: ED vs inpatient vs other routes, time-of-day patterns.
Yield by indication groups and reporting themes.
Identifying potential overuse vs genuine pathology burden.

CT Brain

Demand changes and yield trends over time.
Variation by referral route: ED, inpatient and GP where applicable.
Timing patterns and potential pathway compliance signals.
Opportunities for referral standardisation and vetting improvement.

MRI Lumbar Spine (GP and acute)

Demand and yield by referral source: primary care vs acute.
Appropriateness signals such as repeat imaging intervals and red-flag documentation.
Downstream impact proxies including subsequent imaging or follow-on activity.
Variation between referrers and practices that pathway redesign may improve.

MRI Knees

Demand stratification and variation across referrers.
Yield patterns and likely low-value imaging segments.
Opportunities to support MSK pathways and reduce avoidable demand.

Ultrasound Neck

Referral themes and demand patterns.
Yield proxies from report text: normal or benign vs actionable findings.
Variation across services and potential standardisation opportunities.

Ultrasound Transvaginal

Cohort and indication themes as inferable from referral and report text.
Yield and repeat imaging patterns.
Opportunities to align local practice with best-practice pathways.
How the audit works

End to end, in six stages

01

Scoping and site onboarding

We agree the pathway, key audit questions, time period and data sources. Each pathway is treated as a discrete audit run with clear scope and deliverables.

02

Information governance and contracting

We support completion of IG requirements and contracting via a structured onboarding process. IG is usually the rate-limiting step and the key determinant of the overall timeline.

03

Secure environment and data ingestion

Data is transferred and processed in a secure environment. A validation step confirms the dataset provided matches the agreed specification before processing begins.

04

AI-enabled interrogation

AI methods are applied to radiology report free text and structured fields to extract consistent indicators, classify themes and quantify variation relevant to the pathway questions.

05

Clinical validation

Outputs and any AI-generated recommendations are clinically checked. Validation is performed in batches to ensure results correlate with clinical reality and remain safe and credible.

06

Reporting and insight refinement

We provide a final report including visualisations, narrative interpretation and action-oriented insight. Your team remains responsible for implementing change; optional support can be added.

Imaging and informatics team reviewing audit findings
Deliverables

What you receive

The audit produces a structured set of insights tailored to the pathway, designed so local teams can prioritise interventions.

A pathway-specific report, AI-drafted and clinically reviewed, with executive summary and detailed findings.
Key metrics dashboards and visualisations for demand, yield and variation.
A findings presentation to clinical and operational stakeholders.
Webinars where appropriate to support dissemination and adoption.
A communications summary suitable for governance forums, redactable for broader sharing.
Commercial model

Transparent pricing, priced per pathway

We do not cap the number of records. Exceptionally large or complex datasets may require additional engineering and validation effort and may therefore be priced higher. Indicative pricing for one pathway:

Site initiation
£7,500
7.8 days

Site selection and kick-off; data scoping, preparation and scripts; secure environment setup; information governance completion.

Data analysis and reporting
£12,500
12.5 days

Regular post-IG engagement; data extraction, cleansing and validation; engineering test runs; data visualisation.

Evaluation and closure
£2,500
4 days

Presentation of findings; final AI-drafted, team-reviewed report pack; webinars and stakeholder communication; evaluation and close-out.

Total per pathway
£22,500
excluding VAT

Volume discounts

Up to 10 pathways: £12,500 each (standard rate)
11+ pathways: £10,000 per pathway from the 11th
Practical price floor of £8,000 per pathway, reflecting minimum assurance and clinical validation requirements

Onboarding efficiencies

Once site initiation is complete, effort is typically reduced for subsequent pathways at the same site because IG, contracting and environments are already in place.

Closed-loop re-audit

Recommended as good practice: baseline audit, implement an intervention, then re-audit after a defined period, often 6–12 months. Repeat runs re-use established datasets and pipelines.

Information governance and security

Aligned to NHS and provider requirements

Security controls and data handling arrangements are agreed during onboarding and supported through the initiation phase. IG timelines vary by organisation — early engagement with IG leads materially improves delivery speed.

Defined data specification

Minimum necessary principles applied throughout, with a structured specification and validation checks.

Secure transfer and storage

Transfer and storage arrangements agreed with your organisation during onboarding.

Full audit trail

An audit trail of all ingestion and processing steps is maintained.

Controlled access

Access to outputs and reporting is controlled and agreed in advance.

Getting started

From first call to findings

A typical start process

1
Introductory call to confirm pathway priorities and success criteria.
2
Rapid scoping to agree questions, dataset and timeframe.
3
Initiation: contracting, IG and secure environment set-up.
4
First run: data ingestion, AI interrogation, clinical validation and reporting.
5
Findings presentation and planning for intervention and re-audit.

What we ask you for

A named clinical lead and operational owner for the pathway.
Named IG and data contacts — RIS/PACS, BI/informatics, and pathology where relevant.
An indicative timeframe and preferred reporting format.
Any local pathway documents or guidance to align interpretation.
Typical timelines

Once IG is complete and the dataset is established, analysis and reporting can often be turned around within 2–3 weeks, sometimes faster. Repeat audits are faster still, provided no material data variation is introduced.

Ready to audit your imaging pathway?

Start with an introductory call to confirm your pathway priorities and success criteria. We’ll scope the questions, dataset and timeframe with you.

Book a scoping call